Market Overview:
The global Mupirocin Calcium 2% Cream market is expected to grow at a CAGR of xx.xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of skin infections, increasing demand for mupirocin calcium 2% cream due to its antimicrobial properties, and growing awareness about hygiene and personal care. However, the high cost of mupirocin calcium 2% cream may restrain the growth of this market during the forecast period. Based on type, the global Mupirocin Calcium 2% Cream market can be segmented into 15g/tube and 30g/tube segments. The 30g/tube segment is expected to account for a larger share of the global Mupirocin Calcium 2% Cream market than the 15g/tube segment during the forecast period. This can be attributed to rising demand for large-sized tubes owing to their ease-of-use and convenience in use.
Product Definition:
Mupirocin calcium 2% cream is a topical antibiotic used to treat skin infections. It works by stopping the growth of bacteria. Mupirocin calcium 2% cream is important because it can help clear up skin infections, including impetigo and MRSA (methicillin-resistant Staphylococcus aureus), that other antibiotics may not work against.
15g/tube:
15g/tube is the average amount of Mupirocin calcium 2% Cream used for a single application on axilla or inguinal region. It's usage in skin and tissue culture, bacterial vaginosis diagnosis, food and water contamination testing.
30g/tube:
30g/tube is the standard concentration of Mupirocin calcium 2% Cream. It is used for the treatment of skin infections such as impetigo, cellulitis, and staphylococcal or scalded skin. The cream usually comes in a dark brown glass ampoules with a flip cap closure containing 30 gms of mupirocin in it along with an applicator attached to it.
Application Insights:
The clinics segment held the largest share of over 70.0% in 2017. Mupirocin calcium 2% cream is used for the treatment and prevention of skin infections caused by acne, impetigo, staphylococcus aureus, and Streptococcus pyogenes among others. The hospital segment is expected to witness significant growth owing to rising healthcare spending in emerging economies such as China India Japan Brazil and Mexico which has resulted in increased number of patients visiting hospitals resulting in higher demand for mupirocin calcium 2%.
Mupirocin is an antibiotic that works against bacteria including Staphylococcus aureus (meningitis & osteomyelitis), streptococci (pharyngitis & tonsillitis), Escherichia coli (enteric fever) among others.
Regional Analysis:
North America dominated the global market in 2017 owing to rising incidence of skin-related diseases and increasing number of product launches. Moreover, high adoption rate of advanced therapeutics is also expected to drive the regional demand for mupirocin calcium 2% cream. The U.S., which accounted for a major share in North America, is one of the most developed countries with respect to healthcare infrastructure and availability of advanced products at affordable prices.
In Asia Pacific, Japan held a significant revenue share in 2017 owing to growing medical tourism industry supported by low treatment cost coupled with high quality standards associated with local hospitals & clinics as compared to international destinations.
Growth Factors:
- Increasing incidence of skin infections: The increasing incidence of skin infections is one of the key growth drivers for the Mupirocin Calcium 2% Cream market. This is because Mupirocin Calcium 2% Cream is an effective antibiotic that helps in the treatment of various types of skin infections.
- Rising awareness about benefits of Mupirocin Calcium 2% Cream: The rising awareness about the benefits of using Mupirocin Calcium 2% Cream is another key growth driver for this market. This is because people are becoming increasingly aware about its properties such as its antibacterial and antifungal properties, which make it a useful tool in the treatment of various types of skin infections.
- Growing demand from emerging markets: The growing demand from emerging markets such as India and China is another key growth driver for this market. This is because these countries have a large population base, and also lack adequate healthcare infrastructure, which leads to an increase in the demand for drugs and therapies such as Mupirocin Calcium 2% Cream that can help in treating various diseases and conditions effectively.
Scope Of The Report
Report Attributes
Report Details
Report Title
Mupirocin Calcium 2% Cream Market Research Report
By Type
15g/tube, 30g/tube
By Application
Hospital, Clinics, Recovery Center
By Companies
GSK, Glenmark, Prasco Laboratories, Teva, Actiza Pharmaceutical, Dew Care, Hainan Quanxing Pharmaceutical, Hebei Jiuzheng Yaoye, Hubei Renfu Chengtian Yaoye, Guangdong Hengjian Pharmaceutical, Hangzhou Zhuyangxin Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
185
Number of Tables & Figures
130
Customization Available
Yes, the report can be customized as per your need.
Global Mupirocin Calcium 2% Cream Market Report Segments:
The global Mupirocin Calcium 2% Cream market is segmented on the basis of:
Types
15g/tube, 30g/tube
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GSK
- Glenmark
- Prasco Laboratories
- Teva
- Actiza Pharmaceutical
- Dew Care
- Hainan Quanxing Pharmaceutical
- Hebei Jiuzheng Yaoye
- Hubei Renfu Chengtian Yaoye
- Guangdong Hengjian Pharmaceutical
- Hangzhou Zhuyangxin Pharmaceutical
Highlights of The Mupirocin Calcium 2% Cream Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 15g/tube
- 30g/tube
- By Application:
- Hospital
- Clinics
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mupirocin Calcium 2% Cream Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mupirocin Calcium 2% Cream is a topical cream that contains mupirocin, an antibiotic. It is used to treat skin infections such as acne, eczema, and psoriasis.
Some of the major companies in the mupirocin calcium 2% cream market are GSK, Glenmark, Prasco Laboratories, Teva, Actiza Pharmaceutical, Dew Care, Hainan Quanxing Pharmaceutical, Hebei Jiuzheng Yaoye, Hubei Renfu Chengtian Yaoye, Guangdong Hengjian Pharmaceutical, Hangzhou Zhuyangxin Pharmaceutical.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Mupirocin Calcium 2% Cream Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Mupirocin Calcium 2% Cream Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Mupirocin Calcium 2% Cream Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Mupirocin Calcium 2% Cream Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Mupirocin Calcium 2% Cream Market Size & Forecast, 2020-2028
4.5.1 Mupirocin Calcium 2% Cream Market Size and Y-o-Y Growth
4.5.2 Mupirocin Calcium 2% Cream Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 15g/tube
5.2.2 30g/tube
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Mupirocin Calcium 2% Cream Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Mupirocin Calcium 2% Cream Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 15g/tube
9.6.2 30g/tube
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 15g/tube
10.6.2 30g/tube
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 15g/tube
11.6.2 30g/tube
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 15g/tube
12.6.2 30g/tube
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 15g/tube
13.6.2 30g/tube
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Mupirocin Calcium 2% Cream Market: Competitive Dashboard
14.2 Global Mupirocin Calcium 2% Cream Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GSK
14.3.2 Glenmark
14.3.3 Prasco Laboratories
14.3.4 Teva
14.3.5 Actiza Pharmaceutical
14.3.6 Dew Care
14.3.7 Hainan Quanxing Pharmaceutical
14.3.8 Hebei Jiuzheng Yaoye
14.3.9 Hubei Renfu Chengtian Yaoye
14.3.10 Guangdong Hengjian Pharmaceutical
14.3.11 Hangzhou Zhuyangxin Pharmaceutical
